Clinical Trial

Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Our hypothesis is that S. aureus skin decolonization in atopic dermatitis reduces disease severity and favorably alters the function and gene expression of epidermal and immune skin cells that contribute to disease severity.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2024-04-30; most recent amendment 2026-03-08.
Status change: Withdrawn → Not Yet Recruiting 2024-09-10
Status change: Not Yet Recruiting → Withdrawn 2024-08-06
Trial Details
NCT Number NCT06397781
Lead Sponsor Boston Children's Hospital
Conditions Atopic Dermatitis
Enrollment 100 participants
Start Date 2031-01-01
Primary Completion 2035-12 (estimated)
Study Completion 2039-12 (estimated)
Updated on ClinicalTrials.gov 2026-03-10